Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
Public health strategies are urgently needed to improve HIV disparities among transgender
women, highly burdened by the epidemic globally, including holistic approaches that address
those health needs prioritized by the community. To address this urgent need, a three-phase
implementation science study of an integrated HIV service delivery model that combined HIV
prevention and treatment services with gender-affirming primary medical care for transgender
women was implemented in Lima, Peru, supported by peer navigation to improve outcomes across
the HIV continuum of care: regular HIV testing for HIV-uninfected participants and linkage to
preventive services; and engagement in treatment resulting in viral suppression for
HIV-infected participants.
Phase:
Phase 4
Details
Lead Sponsor:
Asociación Civil Impacta Salud y Educación, Peru
Collaborators:
amfAR, The Foundation for AIDS Research Epicentro The Fenway Institute